Fidelity Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10B | Buy |
71,906,290
+6,326,800
| +10% | +$886M | 0.53% | 24 |
|
|
2025
Q4 | $8.05B | Buy |
65,579,490
+5,263,211
| +9% | +$640M | 0.41% | 29 |
|
|
2025
Q3 | $6.7B | Buy |
60,316,279
+360,902
| +0.6% | +$41M | 0.35% | 35 |
|
|
2025
Q2 | $6.65B | Buy |
59,955,377
+1,412,535
| +2% | +$150M | 0.37% | 30 |
|
|
2025
Q1 | $6.56B | Buy |
58,542,842
+18,223,410
| +45% | +$1.88B | 0.42% | 30 |
|
|
2024
Q4 | $3.72B | Buy |
40,319,432
+7,157,113
| +22% | +$644M | 0.22% | 59 |
|
|
2024
Q3 | $2.78B | Buy |
33,162,319
+14,680,161
| +79% | +$1.12B | 0.17% | 92 |
|
|
2024
Q2 | $1.27B | Buy |
18,482,158
+893,636
| +5% | +$59.6M | 0.08% | 197 |
|
|
2024
Q1 | $1.29B | Buy |
17,588,522
+490,874
| +3% | +$37.7M | 0.09% | 197 |
|
|
2023
Q4 | $1.39B | Sell |
17,097,648
-2,104,011
| -11% | -$164M | 0.11% | 168 |
|
|
2023
Q3 | $1.44B | Sell |
19,201,659
-869,555
| -4% | -$66.9M | 0.12% | 140 |
|
|
2023
Q2 | $1.55B | Sell |
20,071,214
-837,868
| -4% | -$66.8M | 0.13% | 134 |
|
|
2023
Q1 | $1.73B | Buy |
20,909,082
+4,470,179
| +27% | +$370M | 0.16% | 112 |
|
|
2022
Q4 | $1.41B | Buy |
16,438,903
+13,498,403
| +459% | +$1.07B | 0.14% | 128 |
|
|
2022
Q3 | $181M | Buy |
2,940,500
+1,008
| +0% | +$63.6K | 0.02% | 711 |
|
|
2022
Q2 | $182M | Sell |
2,939,492
-3,373,564
| -53% | -$209M | 0.02% | 731 |
|
|
2022
Q1 | $375M | Sell |
6,313,056
-1,509,500
| -19% | -$96.5M | 0.03% | 541 |
|
|
2021
Q4 | $568M | Buy |
7,822,556
+1,504,295
| +24% | +$104M | 0.04% | 420 |
|
|
2021
Q3 | $441M | Buy |
6,318,261
+2,809,204
| +80% | +$197M | 0.04% | 472 |
|
|
2021
Q2 | $242M | Buy |
3,509,057
+942,147
| +37% | +$62.9M | 0.02% | 738 |
|
|
2021
Q1 | $166M | Sell |
2,566,910
-1,190,529
| -32% | -$76.8M | 0.01% | 872 |
|
|
2020
Q4 | $219M | Sell |
3,757,439
-3,952,786
| -51% | -$239M | 0.02% | 710 |
|
|
2020
Q3 | $487M | Sell |
7,710,225
-4,892,313
| -39% | -$339M | 0.05% | 344 |
|
|
2020
Q2 | $970M | Buy |
12,602,538
+1,582,739
| +14% | +$121M | 0.11% | 175 |
|
|
2020
Q1 | $824M | Buy |
11,019,799
+4,752,475
| +76% | +$328M | 0.11% | 161 |
|
|
2019
Q4 | $407M | Sell |
6,267,324
-1,969,055
| -24% | -$128M | 0.04% | 388 |
|
|
2019
Q3 | $522M | Sell |
8,236,379
-4,470,074
| -35% | -$292M | 0.06% | 298 |
|
|
2019
Q2 | $858M | Sell |
12,706,453
-179,260
| -1% | -$11.8M | 0.1% | 200 |
|
|
2019
Q1 | $838M | Sell |
12,885,713
-1,245,515
| -9% | -$82.8M | 0.1% | 191 |
|
|
2018
Q4 | $884M | Sell |
14,131,228
-4,079,394
| -22% | -$285M | 0.12% | 149 |
|
|
2018
Q3 | $1.41B | Sell |
18,210,622
-1,376,432
| -7% | -$104M | 0.16% | 119 |
|
|
2018
Q2 | $1.39B | Sell |
19,587,054
-5,107,836
| -21% | -$361M | 0.16% | 119 |
|
|
2018
Q1 | $1.86B | Buy |
24,694,890
+574,558
| +2% | +$45.7M | 0.22% | 87 |
|
|
2017
Q4 | $1.73B | Sell |
24,120,332
-3,591,334
| -13% | -$273M | 0.2% | 92 |
|
|
2017
Q3 | $2.25B | Buy |
27,711,666
+4,674,363
| +20% | +$357M | 0.27% | 64 |
|
|
2017
Q2 | $1.63B | Buy |
23,037,303
+258,005
| +1% | +$17.2M | 0.2% | 95 |
|
|
2017
Q1 | $1.55B | Sell |
22,779,298
-16,329,195
| -42% | -$1.15B | 0.2% | 96 |
|
|
2016
Q4 | $2.8B | Sell |
39,108,493
-6,485,428
| -14% | -$482M | 0.37% | 43 |
|
|
2016
Q3 | $3.61B | Sell |
45,593,921
-24,318,779
| -35% | -$1.98B | 0.48% | 33 |
|
|
2016
Q2 | $5.83B | Buy |
69,912,700
+1,734,085
| +3% | +$154M | 0.8% | 12 |
|
|
2016
Q1 | $6.26B | Sell |
68,178,615
-5,964,172
| -8% | -$538M | 0.87% | 10 |
|
|
2015
Q4 | $7.5B | Sell |
74,142,787
-7,939,582
| -10% | -$826M | 1.01% | 11 |
|
|
2015
Q3 | $8.06B | Sell |
82,082,369
-4,440,739
| -5% | -$493M | 1.15% | 5 |
|
|
2015
Q2 | $10.1B | Sell |
86,523,108
-5,513,488
| -6% | -$602M | 1.3% | 4 |
|
|
2015
Q1 | $9.03B | Sell |
92,036,596
-2,317,490
| -2% | -$235M | 1.15% | 5 |
|
|
2014
Q4 | $8.89B | Buy |
94,354,086
+1,638,457
| +2% | +$169M | 1.16% | 5 |
|
|
2014
Q3 | $9.87B | Sell |
92,715,629
-6,121,241
| -6% | -$599M | 1.34% | 5 |
|
|
2014
Q2 | $8.19B | Sell |
98,836,870
-6,369,358
| -6% | -$496M | 1.1% | 6 |
|
|
2014
Q1 | $7.45B | Sell |
105,206,228
-5,995,801
| -5% | -$470M | 1.04% | 7 |
|
|
2013
Q4 | $8.36B | Sell |
111,202,029
-4,162,433
| -4% | -$290M | 1.18% | 4 |
|
|
2013
Q3 | $7.25B | Buy |
115,364,462
+2,201,197
| +2% | +$132M | 1.11% | 3 |
|
|
2013
Q2 | $5.8B | Buy |
+113,163,265
| New | +$5.9B | 0.95% | 5 |
|
Other funds holding GILD
VCM
VPM
Fidelity Investments's GILD Position: Q1 2026 in Review
Fidelity Investments increased its Gilead Sciences (GILD) stake by 9.6% in Q1 2026, buying an estimated $886M and bringing the position to 71,906,290 shares worth $10B. The position accounts for 0.53% of the portfolio, ranked #24.
Fidelity Investments first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.1B in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Fidelity Investments held 71,906,290 shares of Gilead Sciences worth $10B as of Q1 2026.
- Fidelity Investments bought 6,326,800 Gilead Sciences shares in Q1 2026, an estimated $886M.
- Gilead Sciences made up 0.53% of Fidelity Investments's portfolio in Q1 2026, its #24 holding.
- Fidelity Investments first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's Gilead Sciences position peaked at $10.1B in Q2 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.